NDC 71288-414-01 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71288-414
- Requested NDC
- 71288-414-01
- Package NDCs from labels
- 71288-414-01, 71288-414-03, 71288-414-02, 71288-414-04, 71288-414-91, 71288-414-92, 71288-414-93, 71288-414-94
- Manufacturer
- Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- Effective date
- 2026-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glycopyrrolate | Meitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 2026-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Glycopyrrolate Injection, USP (For Intramuscular or Intravenous Use) | Meitheal Pharmaceuticals Inc. | 2023-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71288-414-01 | Glycopyrrolate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 6 | |
| 71288-414-02 | Glycopyrrolate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | 6 | |
| 71288-414-03 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 6 | |
| 71288-414-04 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 6 | |
| 71288-414-91 | Glycopyrrolate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 1 | |
| 71288-414-92 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 1 | |
| 71288-414-93 | Glycopyrrolate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | 1 | |
| 71288-414-94 | Glycopyrrolate | 25 in 1 CARTON | INJECTION | 25 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71288-414 | GLYCOPYRROLATE INJECTION [MEITHEAL PHARMACEUTICALS INC.] | 5 | Current NDC, Legacy NDC, 4 package rows | 20231116_02541cfd-b209-49b9-a73f-13ef18dce06d.zip |
| 71288-414 | GLYCOPYRROLATE INJECTION [MEITHEAL PHARMACEUTICALS INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20230119_02f914a8-2356-4525-91ff-cf0c9e41ba23.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-414-01 | ML - Milliliter | 71288-414 | f5fff38b-36ce-4663-8728-bbc950b00876 | 1 | 2022-07-06 |
| 71288-414-02 | ML - Milliliter | 71288-414 | 840f5850-63b0-474b-a77c-dce5a133d348 | 1 | 2022-08-04 |
| 71288-414-03 | ML - Milliliter | 71288-414 | 83d53e58-185a-4a78-a2c7-8871249904fb | 1 | 2022-07-06 |
| 71288-414-04 | ML - Milliliter | 71288-414 | 7eeb2da7-edbf-4246-b5ea-dc49ff7f53aa | 1 | 2022-08-04 |
| 71288-414-91 | ML - Milliliter | 71288-414 | 93b1cfb8-5cae-4638-ab3d-4e8cd036aac6 | 1 | 2023-08-08 |
| 71288-414-92 | ML - Milliliter | 71288-414 | 4ee266fd-f377-4f69-94fe-f952d4b2f15d | 1 | 2023-08-08 |
| 71288-414-93 | ML - Milliliter | 71288-414 | 9bfdc480-17ad-462a-8df4-e412822271ac | 1 | 2023-08-08 |
| 71288-414-94 | ML - Milliliter | 71288-414 | 91e85e8e-6dc8-4139-9c81-28fc6cadc979 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | e8bb95ed-09f1-fcf1-e053-2a95a90a93e5 | 2023-04-25 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | ea4c8be4-a1e9-5901-e053-2995a90a5e63 | 2023-04-24 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| BEVESPI AEROSPHERE | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | ae02436e-9528-490e-a844-0c0f6f2843f9 | 2023-03-24 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 3ac4f32f-f5ca-4a6d-9bc7-2672d478b3d4 | 2023-03-01 | Warnings, Adverse reactions | 1731582 V92SO9WP2I |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Acidum Muriaticum | ACIDUM MURIATICUM | Hahnemann Laboratories, INC. | f2aad04c-5151-6cab-e053-2a95a90ad3a7 | 2023-01-19 | QTT17582CB | |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02f914a8-2356-4525-91ff-cf0c9e41ba23 | 2023-01-12 | Warnings, Adverse reactions | ANDA212802 71288-415-97 71288-414-93 71288-414-91 71288-415-95 71288-415-96 71288-414-94 71288-415-98 71288-414-92 71288-414 71288-415 1731582 1731590 238212 c229ab19-8e9b-49ee-8d8f-0ed2f12d01b1 02f914a8-2356-4525-91ff-cf0c9e41ba23 V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Quinn Pharmaceuticals | e1ded8e0-c05b-4bf4-a129-57d1726af6ed | 2022-12-20 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 26cdd84d-ffa0-4e52-b359-4acef4bd8093 | 2022-11-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | b45e9f1d-9c48-4b46-8541-d846b89540df | 2022-10-26 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye wash | PURIFIED WATER | McKesson | bd089fde-24ba-4de5-e053-2995a90a39bb | 2022-10-18 | Warnings | 059QF0KO0R |
| Bach Original Flower Remedies Rock Water | WATER | Nelson Bach USA Limited | ea242559-1618-3354-e053-2a95a90a1a95 | 2022-10-03 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Medical Purchasing Solutions, LLC | e90b47e3-9636-b9ee-e053-2a95a90ad48c | 2022-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Camber Pharmaceuticals, Inc. | 4741be85-3abb-4545-aba9-281f64d210ec | 2022-07-13 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Novadoz Pharmaceuticals LLC | 98820c01-1853-45d8-9da5-875fcdf5f9ab | 2022-06-14 | Warnings, Adverse reactions | V92SO9WP2I |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed LLC | 29618edf-39b0-022a-9875-9d865450d318 | 2022-04-12 | Warnings, Adverse reactions | 1731582 1731590 238212 V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.